These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 27311442)

  • 1. High-throughput functional comparison of promoter and enhancer activities.
    Nguyen TA; Jones RD; Snavely AR; Pfenning AR; Kirchner R; Hemberg M; Gray JM
    Genome Res; 2016 Aug; 26(8):1023-33. PubMed ID: 27311442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional genome architectural CCCTC-binding factor makes choice in duplicated enhancers at Pcdhα locus.
    Wu Y; Jia Z; Ge X; Wu Q
    Sci China Life Sci; 2020 Jun; 63(6):835-844. PubMed ID: 32249388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental acquisition of enhancer function requires a unique coactivator activity.
    Majumder S; Zhao Z; Kaneko K; DePamphilis ML
    EMBO J; 1997 Apr; 16(7):1721-31. PubMed ID: 9130716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter-distal RNA polymerase II binding discriminates active from inactive CCAAT/ enhancer-binding protein beta binding sites.
    Savic D; Roberts BS; Carleton JB; Partridge EC; White MA; Cohen BA; Cooper GM; Gertz J; Myers RM
    Genome Res; 2015 Dec; 25(12):1791-800. PubMed ID: 26486725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The degree of enhancer or promoter activity is reflected by the levels and directionality of eRNA transcription.
    Mikhaylichenko O; Bondarenko V; Harnett D; Schor IE; Males M; Viales RR; Furlong EEM
    Genes Dev; 2018 Jan; 32(1):42-57. PubMed ID: 29378788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of sequence determinants of enhancer function using natural genetic variation.
    Yang MG; Ling E; Cowley CJ; Greenberg ME; Vierbuchen T
    Elife; 2022 Aug; 11():. PubMed ID: 36043696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic mapping of putative Chrna7 and Luzp2 neuronal transcriptional enhancers due to impact of a transgene-insertion and 6.8 Mb deletion in a mouse model of Prader-Willi and Angelman syndromes.
    Stefan M; Claiborn KC; Stasiek E; Chai JH; Ohta T; Longnecker R; Greally JM; Nicholls RD
    BMC Genomics; 2005 Nov; 6():157. PubMed ID: 16280085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility rules of human enhancer and promoter sequences.
    Bergman DT; Jones TR; Liu V; Ray J; Jagoda E; Siraj L; Kang HY; Nasser J; Kane M; Rios A; Nguyen TH; Grossman SR; Fulco CP; Lander ES; Engreitz JM
    Nature; 2022 Jul; 607(7917):176-184. PubMed ID: 35594906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription start site analysis reveals widespread divergent transcription in D. melanogaster and core promoter-encoded enhancer activities.
    Rennie S; Dalby M; Lloret-Llinares M; Bakoulis S; Dalager Vaagensø C; Heick Jensen T; Andersson R
    Nucleic Acids Res; 2018 Jun; 46(11):5455-5469. PubMed ID: 29659982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long distance relationships: enhancer-promoter communication and dynamic gene transcription.
    Marsman J; Horsfield JA
    Biochim Biophys Acta; 2012; 1819(11-12):1217-27. PubMed ID: 23124110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinatorial control of the bradykinin B2 receptor promoter by p53, CREB, KLF-4, and CBP: implications for terminal nephron differentiation.
    Saifudeen Z; Dipp S; Fan H; El-Dahr SS
    Am J Physiol Renal Physiol; 2005 May; 288(5):F899-909. PubMed ID: 15632413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergism between immunoglobulin enhancers and promoters.
    Garcia JV; Bich-Thuy LT; Stafford J; Queen C
    Nature; 1986 Jul 24-30; 322(6077):383-5. PubMed ID: 3016550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A unified architecture of transcriptional regulatory elements.
    Andersson R; Sandelin A; Danko CG
    Trends Genet; 2015 Aug; 31(8):426-33. PubMed ID: 26073855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic interrogation of human promoters.
    Weingarten-Gabbay S; Nir R; Lubliner S; Sharon E; Kalma Y; Weinberger A; Segal E
    Genome Res; 2019 Feb; 29(2):171-183. PubMed ID: 30622120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter elements and transcription factors involved in differentiation-dependent human chorionic gonadotrophin-alpha messenger ribonucleic acid expression of term villous trophoblasts.
    Knöfler M; Saleh L; Bauer S; Vasicek R; Griesinger G; Strohmer H; Helmer H; Husslein P
    Endocrinology; 2000 Oct; 141(10):3737-48. PubMed ID: 11014230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory Enhancer-Core-Promoter Communication via Transcription Factors and Cofactors.
    Zabidi MA; Stark A
    Trends Genet; 2016 Dec; 32(12):801-814. PubMed ID: 27816209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence Characteristics Distinguish Transcribed Enhancers from Promoters and Predict Their Breadth of Activity.
    Colbran LL; Chen L; Capra JA
    Genetics; 2019 Apr; 211(4):1205-1217. PubMed ID: 30696717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of a CTCF-Dependent Insulator on Multiple Aspects of Enhancer-Mediated Chromatin Organization.
    Varma G; Rawat P; Jalan M; Vinayak M; Srivastava M
    Mol Cell Biol; 2015 Oct; 35(20):3504-16. PubMed ID: 26240285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel enhancer element in the human IL-4 promoter is suppressed by a position-independent silencer.
    Li-Weber M; Krafft H; Krammer PH
    J Immunol; 1993 Aug; 151(3):1371-82. PubMed ID: 8393045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of enhancer-promoter interactions by insulators in the Drosophila embryo.
    Cai H; Levine M
    Nature; 1995 Aug; 376(6540):533-6. PubMed ID: 7637789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.